These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. Kim CK, Rivier C. J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649 [Abstract] [Full Text] [Related]
3. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis. Mandai M, Mittag TW, Kogishi J, Iwaki M, Hangai M, Yoshimura N. Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):826-32. PubMed ID: 8603867 [Abstract] [Full Text] [Related]
4. Expression of nitric oxide and inducible nitric oxide synthase in acute renal allograft rejection in the rat. Suzuki A, Kudoh S, Mori K, Takahashi N, Suzuki T. Int J Urol; 2004 Oct; 11(10):837-44. PubMed ID: 15479287 [Abstract] [Full Text] [Related]
5. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Tozer GM, Prise VE, Chaplin DJ. Cancer Res; 1997 Mar 01; 57(5):948-55. PubMed ID: 9041200 [Abstract] [Full Text] [Related]
6. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Millar CG, Thiemermann C. Br J Pharmacol; 1997 Aug 01; 121(8):1824-30. PubMed ID: 9283724 [Abstract] [Full Text] [Related]
7. Roles of constitutive nitric oxide synthase in postischemic rat retina. Hangai M, Miyamoto K, Hiroi K, Tujikawa A, Ogura Y, Honda Y, Yoshimura N. Invest Ophthalmol Vis Sci; 1999 Feb 01; 40(2):450-8. PubMed ID: 9950605 [Abstract] [Full Text] [Related]
8. Nitric oxide synthase (NOS) inhibitors ameliorate retinal damage induced by ischemia in rats. Lam TT, Tso MO. Res Commun Mol Pathol Pharmacol; 1996 Jun 01; 92(3):329-40. PubMed ID: 8827830 [Abstract] [Full Text] [Related]
9. Effect of nitric oxide synthase modulation on resuscitation success in a swine ventricular fibrillation cardiac arrest model. Zhang Y, Boddicker KA, Rhee BJ, Davies LR, Kerber RE. Resuscitation; 2005 Oct 01; 67(1):127-34. PubMed ID: 16039037 [Abstract] [Full Text] [Related]
10. [Hemodynamic effects of sub-chronic NO synthase inhibition in conscious dogs: role of EDRF/NO in muscular exertion]. Puybasset L, Béa ML, Simon L, Ghaleh B, Giudicelli JF, Berdeaux A. Arch Mal Coeur Vaiss; 1995 Aug 01; 88(8):1217-21. PubMed ID: 8572877 [Abstract] [Full Text] [Related]
11. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape. Hu L, Sealey JE, Chen R, Zhou Y, Merali C, Shi Y, Laragh JH, Catanzaro DF. Am J Hypertens; 2004 May 01; 17(5 Pt 1):395-403. PubMed ID: 15110897 [Abstract] [Full Text] [Related]
12. Enhanced nitric oxide production induced by the administration of L-arginine does not inhibit arterial neointimal formation after overwhelming alloimmune injury. Gregory CR, Cooke JP, Patz JD, Berryman ER, Shorthouse R, Morris RE. J Heart Lung Transplant; 1996 Jan 01; 15(1 Pt 1):58-66. PubMed ID: 8820084 [Abstract] [Full Text] [Related]
13. Transcriptome-based identification of pro- and antioxidative gene expression in kidney cortex of nitric oxide-depleted rats. Wesseling S, Joles JA, van Goor H, Bluyssen HA, Kemmeren P, Holstege FC, Koomans HA, Braam B. Physiol Genomics; 2007 Jan 17; 28(2):158-67. PubMed ID: 17047089 [Abstract] [Full Text] [Related]
14. Protective role of endogenous nitric oxide (NO) in lipopolysaccharide--induced pancreatic damage (a new experimental model of acute pancreatitis). Jaworek J, Jachimczak B, Bonior J, Kot M, Tomaszewska R, Karczewska E, Stachura J, Pawlik W, Konturek SJ. J Physiol Pharmacol; 2000 Mar 17; 51(1):85-102. PubMed ID: 10768853 [Abstract] [Full Text] [Related]
15. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts. Kobara M, Tatsumi T, Takeda M, Mano A, Yamanaka S, Shiraishi J, Keira N, Matoba S, Asayama J, Nakagawa M. Basic Res Cardiol; 2003 Sep 17; 98(5):319-28. PubMed ID: 12955405 [Abstract] [Full Text] [Related]
16. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer. Camp ER, Yang A, Liu W, Fan F, Somcio R, Hicklin DJ, Ellis LM. Clin Cancer Res; 2006 Apr 15; 12(8):2628-33. PubMed ID: 16638876 [Abstract] [Full Text] [Related]
17. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Reif DW, McCreedy SA. Arch Biochem Biophys; 1995 Jun 20; 320(1):170-6. PubMed ID: 7540822 [Abstract] [Full Text] [Related]
18. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. Tilton RG, Chang KC, LeJeune WS, Stephan CC, Brock TA, Williamson JR. Invest Ophthalmol Vis Sci; 1999 Mar 20; 40(3):689-96. PubMed ID: 10067972 [Abstract] [Full Text] [Related]
19. Role of nitric oxide synthase inhibition in leukocyte-endothelium interaction in the rat pial microvasculature. Lindauer U, Dreier J, Angstwurm K, Rubin I, Villringer A, Einhäupl KM, Dirnagl U. J Cereb Blood Flow Metab; 1996 Nov 20; 16(6):1143-52. PubMed ID: 8898686 [Abstract] [Full Text] [Related]
20. Skeletal muscle and jejunal protein synthesis in normal and ethanol-treated rats: the effect of the nitric oxide synthase inhibitors, L-omega-nitro-L-arginine methyl ester and N(G)-nitro-L-arginine in vivo. Rajendram R, Marway JS, Mantle D, Peters TJ, Preedy VR. Metabolism; 2003 Apr 20; 52(4):397-401. PubMed ID: 12701048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]